骨密度

ɡǔ mì dù
  • bone mineral density;BMD
骨密度骨密度
  1. 目的观察肌注鲑鱼降钙素对并骨质疏松症的髋部骨折患者骨密度的影响。

    Objective to assess the effects of salmon calcitonin on bone mineral density in osteoporosis patients with hip fracture .

  2. 长春地区359例正常男性骨密度定量CT测量研究

    Quantitative investigation of bone mineral density in 359 normal men in Changchun area

  3. Access数据库软件在双能X线骨密度仪数据管理中的应用

    Application of Microsoft Access in database management from dual-energy X-ray absorptiometry

  4. 定量CT测量骨密度的准确性研究

    Accuracy of quantitative CT in measuring bone mineral density

  5. 结果X线片示A组右侧股骨头骨密度增高,透光区较小,B组骨密度减低,有大小不等透光区;

    Results X-ray showed that bone density of the right side increases and the transparent area is relatively small in the experimental group .

  6. 跟骨骨密度的T值有显著性提高,Z值并无明显改变。

    Calcaneal bone-density T values have improved significantly , Z value and no obvious change .

  7. 营养状态、肺功能指标为影响COPD患者骨密度的相关因素。

    BMD in patients with COPD is correlated with the nutritional state and lung function .

  8. 目的研究人股骨头主要承重区骨密度(Bonemineraldensity,BMD)与骨生物力学相关性;

    Objective 1 . To explore the relation between bone mineral density ( BMD ) and bone biomechanics of femoral head ( FH ) .

  9. 结果在PP型,低体重是股骨颈、大转子骨密度的危险因素;

    Results In PP genotype patients , lower body weight was the risk factor for low BMD in neck and trochanter .

  10. 废用股骨的骨密度(BMD)分别降低11.1%和15.5%。

    Bone density of the disused femur decreased 11.1 % and 15.5 % , respectively .

  11. 低骨密度(BMD)是骨质疏松性骨折(OF)的重要危险因子。

    Low BMD is recognized as a major risk factor for osteoporotic fracture ( OF ) .

  12. 目的:通过定量CT(QCT)检查,了解骨密度(BMD)的变化情况,以期对骨量减少及骨质疏松症(OP)的早期诊断和防治为临床提供帮助。

    Purpose : Quantitative CT adjust bone mineral density measurement to be help for clinical diagnostic and prevention .

  13. 为了研究体成分与骨密度(BMD)之间的关系,因体重与BMD显著相关,体成分各个组成相加等于体重,而体成分与BMD的关系仍不清楚。

    To study the relationship between body weight , body composition and bone mineral density ( BMD ) .

  14. 流行病学研究发现,在摄入豆制品较高的亚洲地区绝经后妇女中,其膳食SI摄入水平与骨密度之间呈显著正相关。

    Epidemiologic studies found that , there was positive correlation between amount of SI intake and BMD in Asian post-menopause women with high intake of bean product .

  15. 目的探讨降钙素受体(calcitoninreceptor,CTR)基因多态性与绝经前和绝经后妇女骨密度(Bonemineraldensity,BMD)之间的关系。

    Objective To investigate the association of calcitonin receptor ( CTR ) gene polymorphism with bone mineral density ( BMD ) in premenopausal and postmenopausal women .

  16. OA组与对照组的指骨骨密度(BMD)、体重指数(BMI)均无差异(P>0.05)。

    There no difference of the phalange BMD and BMI between OA group and control group neither ( P > 0.05 ) .

  17. 主要观察指标两组患者治疗前及治疗6个月后L2~4和股骨上端的骨密度。

    MAIN OUTCOME MEASURES : BMD of L2-4 and upper end of femur before and 6 months after treatment in two groups .

  18. COPD患者骨密度与用力肺活量(FVC%)、一秒钟用力呼气量(FEV1%)及一秒率(FEV1/FVC%)均呈显著正相关(P<0.05)。

    BMD in COPD patients was positively correlated with FVC % , FEV1 % and FEV1 / FVC % ( P < 0.05 ) .

  19. 在多个影响因素中钙是影响BMD的主要因素,健康的生活习惯和合理膳食有可能预防骨密度降低。

    Calcium play an important role for BMD compared with other factors . Healthy lifestyle and reasonable diet would be useful for BMD .

  20. 骨密度水平T2DM患者较正常组低。

    Bone mineral density level of patients with type 2 diabetes was lower than normal group .

  21. 结果MMP-1与骨密度及骨转换生化指标无明显相关性;

    Results There was no significant correlation between MMP-1 and BMD as well as bone turnover biochemical markers .

  22. 结果12周后,OVX组大鼠骨密度计骨形态学计量指标明显低于Sham组、O+E、O+P及O+E+P组(P<0.05)。

    Results After 12 weeks , the BMD and the Histomorphometry numerical value decreased in OVX rats ( O + P group ) ( P < 0.05 ) .

  23. 远期疾病复发率7%(3/44)较对照组26%(8/31)低,骨密度值较对照组有显著提高,差异有显著意义(P<0.01)。

    Long-term recurrence rate in treatment group was 7 % ( 3 / 44 ), lower than that in the control 26 % ( 8 / 31 ); bone density improved obviously comparing with the control ( P < 0.01 ) .

  24. 目的探讨老年男性增龄与骨密度(BMD)和钙调节激素的关系。

    Objective To investigate the relationship between aging and bone mineral density ( BMD ) as well as related calcium modulator hormone in aged men .

  25. 方法用SPA法和US法对45例健康人,32例卧床2月病人和48例胸腰段脊髓损伤2月患者行骨密度测量。

    Methods The bone density was measured by SPA and US in 45 healthy people , 32 patients bed ridden for 2 months and 48 patients with thoracolumbar spinal cord injury suffered for 2 months .

  26. 实验8wk后,测骨密度、血AKP、MDA、24h尿钙、氟及尿肌酐含量。

    The BMC , BMD , serum MDA , 24h urinary calcium , zinc , copper , fluorine and urinary Cr were determined in experimental 8w .

  27. 绝经后妇女骨质疏松患者血清IGF-1、IGFBP-3与骨密度及骨代谢指标的关系

    The relationship between serum IGF-1 , IGFBP-3 levels , bone mineral density and bone metabolic markers in postmenopausal patients with osteoporosis

  28. 正常人腰椎骨密度变化&445例QCT测量分析

    Normal Spinal Changes of Bone Mineral Density in 445 Individuals : Assessment by Quantitative Computed Tomography

  29. 结果:A组和B组骨密度分别为0.109和0.150mg/cm2,两组之间统计学上无显著性差异(P>0.05)。

    New bone formation was accounted through liner intercept technique . Result ; Bone density of the fusion mass was 0.109 and 0.150 mg / cm2 for group A and B , they were no significantly different ( P > 0.05 ) .

  30. 老年原发性骨质疏松患者血清IGF-1、IGF-BP-3水平与骨密度及骨折的关系

    Relationship between serum IGF-1 and IGF-BP-3 levels and BMD and fracture in patients with osteoporosis